Latest news with #FORTE
Business Upturn
5 days ago
- Business
- Business Upturn
Icertis CEO Samir Bodas to Become Executive Chairman; Chief Operating Officer Anand Subbaraman Appointed as CEO
Business Wire India Icertis, the global leader in AI-powered contract intelligence, today announced that its CEO and Co-founder, Samir Bodas, will become Executive Chairman after more than 15 years of visionary leadership. Chief Operating Officer, Anand Subbaraman, has been appointed Chief Executive Officer. Samir co-founded Icertis in 2009 with Monish Darda, growing the business to become the undisputed category leader approaching $350 million in annual recurring revenue. In that time, Samir illuminated the strategic role that contracts play in enterprise-wide digital transformation, drove deep partnerships with hyper-scalers and the largest system integrators, and established contract intelligence as a critical system of record used by more than one third of the Fortune 100. 'In the age of 'AI everything', where technology is transforming both companies and whole industries, Anand's extensive experience in building amazing products, operational depth in delivering to customers at scale, and core values grounded in FORTE make him an ideal fit to take Icertis into the future,' said Samir. 'Over the last 15 years, we have built category-defining products to help our customers derive exceptional value by transforming their end-to-end contracting – the foundation of all commerce. As I focus on my health, the time is right for Anand to step into the CEO role and take Icertis to the next level. I look forward to partnering closely with him as we continue to launch breakthrough innovations.' Anand's 25-year track record of driving strategy and engineering spans global enterprise software companies including Oracle, BrowserStack, and Finastra. During his tenure as COO at Icertis, Anand has expanded his remit across core lines of business while playing a pivotal role in enabling AI innovation and elevating strategic partnerships. Under Anand's direction, Icertis will further its mission of empowering customers to realize the full potential of every business relationship, continue to deliver trusted AI, and enable even more enterprises globally to leverage contracts as strategic drivers of value. 'Enterprise technology sits at a critical inflection point, and Icertis continues to deliver unique and differentiated contact intelligence through our vast data assets, contract-specific AI, agents and co-pilots, and our Contract Intelligence platform to create fast, measurable ROI for customers,' said Anand. 'I am honored to lead Icertis and our incredible team of Icertians to realize the company's bold vision for the future of commerce – powered by contract intelligence.' 'As global commerce is reinvented in today's business landscape, trust and agility in relationships has never been more critical. Icertis is transforming how the world's most vital commercial relationships are negotiated and managed – and setting the standard for innovation at a pivotal moment,' said Penny Pritzker, Lead Independent Icertis Director. 'Icertis is uniquely positioned to lead the next wave of enterprise AI by elevating contracts as one of the most powerful business assets in every industry. I am confident in Anand's ability to take the helm and advance the company's mission.' Contracts are the foundation of every business relationship, establishing the rules for how enterprises buy, sell, and partner to drive their global commerce. Icertis Contract Intelligence creates a single source of truth for relationships, delivering analytics, operations, and performance in one platform to surface profit-powering insights, optimize negotiations, and put contract terms to work post-signature to maximize revenue and savings. About Icertis Icertis delivers AI-powered insights and agentic automation to transform static contracts into strategic enterprise advantage. The Icertis Contract Intelligence platform revolutionizes how enterprises manage their customer, supplier, and partner relationships, enabling businesses to grow revenue, control costs, mitigate risk, and ensure compliance. Today, more than one third of the Fortune 100 trust Icertis to realize the full potential of millions of business relationships in more than 90 countries around the world. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
Techday NZ
5 days ago
- Business
- Techday NZ
Anand Subbaraman named CEO as Icertis nears USD $350 million
Icertis has announced a change in its executive leadership as Anand Subbaraman is appointed Chief Executive Officer, with Samir Bodas transitioning to the role of Executive Chairman. The company, known for its focus on AI-powered contract intelligence, was co-founded in 2009 by Samir Bodas and Monish Darda. Over more than a decade, Icertis has expanded its footprint in the enterprise contract management sector, reporting annual recurring revenue approaching USD $350 million. Samir Bodas, who has led the organisation as CEO for over 15 years, will now assume the role of Executive Chairman. He has overseen the firm's evolution from start-up to a provider whose solutions are reportedly used by more than one third of the Fortune 100. According to the company, under Bodas's leadership, Icertis illuminated the strategic importance of contracts in digital transformation efforts across industries, fostering partnerships with cloud providers and large systems integrators. "In the age of 'AI everything', where technology is transforming both companies and whole industries, Anand's extensive experience in building amazing products, operational depth in delivering to customers at scale, and core values grounded in FORTE make him an ideal fit to take Icertis into the future. Over the last 15 years, we have built category-defining products to help our customers derive exceptional value by transforming their end-to-end contracting – the foundation of all commerce. As I focus on my health, the time is right for Anand to step into the CEO role and take Icertis to the next level. I look forward to partnering closely with him as we continue to launch breakthrough innovations," said Samir. Anand Subbaraman brings over 25 years of international experience in enterprise software, having worked at companies including Oracle, BrowserStack, and Finastra. Since joining Icertis as Chief Operating Officer, Subbaraman has overseen several core business functions and been credited with enabling the company's push into AI and deepening key strategic partnerships. "Enterprise technology sits at a critical inflection point, and Icertis continues to deliver unique and differentiated contact intelligence through our vast data assets, contract-specific AI, agents and co-pilots, and our Contract Intelligence platform to create fast, measurable ROI for customers. I am honoured to lead Icertis and our incredible team of Icertians to realize the company's bold vision for the future of commerce – powered by contract intelligence," said Anand. Penny Pritzker, the Lead Independent Icertis Director, commented on the leadership transition and the company's long-term outlook in the current technological landscape. "As global commerce is reinvented in today's business landscape, trust and agility in relationships has never been more critical. Icertis is transforming how the world's most vital commercial relationships are negotiated and managed – and setting the standard for innovation at a pivotal moment. Icertis is uniquely positioned to lead the next wave of enterprise AI by elevating contracts as one of the most powerful business assets in every industry. I am confident in Anand's ability to take the helm and advance the company's mission," said Penny Pritzker. The Icertis Contract Intelligence platform aims to provide organisations with a centralised system for managing customer, supplier, and partner contracts. The system is intended to streamline analytics and operations, with the goal of helping businesses realise financial and operational efficiencies while meeting compliance requirements. The company reports that its platform delivers analytics, operations, and performance management in a single system, offering insights intended to enhance negotiations and maximise post-signature value. With customers in more than 90 countries, Icertis states it supports millions of business relationships across global industries. Follow us on: Share on:
Broadcast Pro
18-07-2025
- Business
- Broadcast Pro
CT Middle East makes major investment in Robe lighting equipment
All the newly acquired equipment is part of CTME's rental inventory and is already in use across the company's packed lineup of shows, concerts, events and high-profile projects throughout the region. Creative Technology Middle East (CTME) has expanded its rental inventory with a major acquisition of new Robe lighting equipment. The latest purchase includes a wide array of fixtures such as 60 iFORTES, 60 iFORTE LTXs, 8 iFORTE LTX FS Cameras, 80 iTetra2 LED battens, 100 LEDBeam 350s, 12 iBOLTS and 4 RoboSpot BaseStations, bringing the total number of RoboSpots owned by CTME to eight. This follows an earlier procurement earlier in the year, which included 24 FORTES and another 80 LEDBeam 350s, along with four RoboSpots. All the new equipment has already been deployed across CTME's packed calendar of concerts, shows, corporate events and large-scale spectaculars throughout the Middle East. According to Sam Connolly, CTME's Head of Lighting & Power, the purchases are aimed at reinforcing their rental stock to meet increasing demand. He noted the advantage of mixing IP and non-IP versions of the FORTE range due to their visual and performance uniformity, offering maximum flexibility for different production environments. After an extensive market evaluation, CTME selected the iTetra2 as their go-to IP-rated LED batten. Connolly cited its superior light output, creative effects and practical design as the decisive factors. The iBOLTS, praised for their innovative technology, have already been used to dramatic effect at events such as the Sir Bani Yas 2024 gathering, a VIP reception in Al Ain and the Richard Mille Awards at The Louvre Abu Dhabi. The new fixtures have played a key role in recent high-profile productions. At Hans Zimmer Live at Dubai's Coca-Cola Arena, iTetra2s added vibrant colour and fluid motion to the cinematic concert experience. Meanwhile, the iFORTE LTX fixtures took centre stage during Maroon 5's headline act at the Formula 1 Qatar Grand Prix, delivering power and precision at Lusail International Circuit for both in-person and broadcast audiences. CTME's lighting solutions also shone at the Longines Global Champions Tour in Saudi Arabia, where the iFORTE and iFORTE LTX helped designer Roland Greil and his team provide consistent, high-quality coverage across the venue. Connolly explained that the earlier delivery of FORTE and LEDBeam 350s was so successful and in-demand that the team opted to significantly expand their stock—particularly favouring IP-rated versions for outdoor work. He noted that the LEDBeam 350s are among the most-used units, consistently in rotation from CTME's new Dubai headquarters and warehouse. The expansion to eight RoboSpot systems was driven by strong demand for remote follow-spotting capabilities. Robe fixtures are also highly favoured in cross-rental networks, which influenced CTME's confidence in making such a substantial commitment. CTME prioritises reliability and ease of use in its equipment investments. Connolly praised Robe's performance record and the 24-hour technical support provided by Elie Battah, Patrick Haddad and the Robe Middle East team. He also highlighted the practical advantage of Robe's design, such as the elimination of vacuum kits when fitting custom gobos in the iFORTES, which saves time on the job. With operations spanning the UAE, Saudi Arabia and Qatar, Creative Technology Middle East continues to enhance its inventory to support the region's thriving live events sector. Known for delivering world-class technical design and production, the company remains at the forefront of innovation in the Middle Eastern events industry.
Yahoo
25-03-2025
- Business
- Yahoo
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025
PHILADELPHIA, March 25, 2025--(BUSINESS WIRE)--FORE Biotherapeutics, a registration stage biotherapeutics company dedicated to developing targeted therapies to treat patients with cancer, today announced two plixorafenib abstracts have been selected for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30 in Chicago. The first poster features important results showing that circulating tumor DNA (ctDNA) accurately detects BRAF mutations from tumor biopsies and may be a surrogate marker for monitoring disease. The ctDNA results are from plixorafenib-treated patients and were an exploratory endpoint from a previously completed Phase 1/2a study. The second poster highlights the study design for the recently commenced Phase 2 FORTE basket study evaluating plixorafenib in patients with various types of BRAF-mutated tumors. "Plixorafenib's unique paradox breaking mechanism of action in tumors with BRAF alterations underscores its potential to redefine the standard of care for a patient population that has long been underserved and underpenetrated due to the limitations of current agents," said William Hinshaw, Chief Executive Officer of Fore. "We are excited to share these compelling data with the medical community at AACR this year. We believe these results continue to support plixorafenib's favorable product profile as a differentiated molecule and a potential best in class agent in the treatment of BRAF-driven tumors." Poster Presentation Details: Title: Circulating tumor DNA analysis of patients with BRAF-mutated advanced unresectable solid tumors treated with plixorafenib (FORE8394/PLX8394) in Phase 1/2a studyPoster Session: Liquid Biopsy Circulating Nucleic Acids 1Date and Time: Monday, April 28, 2025, 2:00 – 5:00 p.m. CTAbstract Number: 3248Presenter: Rona Yaeger, M.D., Memorial Sloan Kettering Cancer Center Title: FORTE: A phase 2 master protocol assessing plixorafenib for BRAF-altered cancersPoster Session: Late Breaking and Clinical Trials – Phase II and Phase III Clinical Trials in ProgressDate and Time: Tuesday, April 29, 2025, 2:00 – 5:00 p.m. CTAbstract Number: CT247Presenter: Karisa C. Schreck, M.D., Ph.D., Johns Hopkins University About FORE Biotherapeutics Fore is a registration stage targeted oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat cancers. The Company's lead asset plixorafenib (FORE8394; formerly PLX8394) is a V600 and non-V600 BRAF inhibitor rationally designed with a first-in-class mechanism to address treatment gaps from 1st and 2nd generation BRAF inhibitors. Plixorafenib has demonstrated single-agent efficacy signals across a variety of tumor types with a manageable safety profile in a Phase 1/2a clinical trial of over 100 patients and is currently enrolling patients in FORTE, a global registrational basket trial to support three distinct indications. For more information, please visit or follow us on X and LinkedIn. View source version on Contacts Investors and Media: Argot Partners212.600.1902 | ForeBio@ Sign in to access your portfolio
